Type 2 Diabetes and Glycemic Variability: Various Parameters in Clinical Practice

about

Type 2 Diabetes and Glycemic Variability: Various Parameters in Clinical Practice

Item

http://www.wikidata.org/entity/Q58754784

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Type 2 Diabetes and Glycemic Variability: Various Parameters in Clinical Practice

@en

Type 2 Diabetes and Glycemic Variability: Various Parameters in Clinical Practice

@nl

type

Item

label

Type 2 Diabetes and Glycemic Variability: Various Parameters in Clinical Practice

@en

Type 2 Diabetes and Glycemic Variability: Various Parameters in Clinical Practice

@nl

prefLabel

Type 2 Diabetes and Glycemic Variability: Various Parameters in Clinical Practice

@en

Type 2 Diabetes and Glycemic Variability: Various Parameters in Clinical Practice

@nl

P1476

Type 2 Diabetes and Glycemic Variability: Various Parameters in Clinical Practice

@en

P2093

Masaya Sakamoto

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Effects of intensive glucose lowering in type 2 diabetes

Glucose control and vascular complications in veterans with type 2 diabetes

Association of the average rate of change in HbA1c with severe adverse events: a longitudinal evaluation of audit data from the Bavarian Disease Management Program for patients with type 2 diabetes mellitus.

Mean blood glucose and biological variation have greater influence on HbA1c levels than glucose instability: an analysis of data from the Diabetes Control and Complications Trial.

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.

Visit-to-visit glycemic variability is a strong predictor of chronic obstructive pulmonary disease in patients with type 2 diabetes mellitus: Competing risk analysis using a national cohort from the Taiwan diabetes study.

Hypoglycemia, diabetes, and cardiovascular events.

GlyCulator: a glycemic variability calculation tool for continuous glucose monitoring data.

P304

737-742

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.14740/JOCMR3556W

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30214644

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

6135001

http://www.w3.org/2001/XMLSchema#string